Can blood pressure meds after delivery keep new moms out of the hospital?

NCT ID NCT04298034

Ongoing Disease control Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This study tests whether giving blood pressure medication to women after childbirth can prevent hospital readmissions and reduce severe high blood pressure. About 300 women with preeclampsia will either receive standard care or start blood pressure drugs like labetalol or nifedipine. The goal is to see if treatment lowers the need for extra medical visits and improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Labetalol and Nifedipine (blood pressure medications)
What this could lead to: If successful, this could show that treating high blood pressure after childbirth reduces hospital readmissions and the need for extra doctor visits for women with preeclampsia.
What could go wrong: This is a Phase 3 trial, but it only compares treatment to no treatment, not to a placebo. Results may not apply to all women, and the medications can have side effects like dizziness or fatigue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION IN PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION IN PREGNANCY PREECLAMPSIA

Contacts and locations

Locations

Medical College of Wisconsin-Froedtert Hospital

Milwaukee, Wisconsin, 53226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.